{
    "body": "What is the clinical indication of cardiac T1 mapping magnetic resonance?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23564562", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22720998", 
        "http://www.ncbi.nlm.nih.gov/pubmed/12765114", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24518490", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24036385", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24566951", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25310419", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24011774", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17896383", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23549230", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22279111", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24425501", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24931636", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21974927", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23071146", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23349348", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23643513", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24903343", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17659622", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22967246", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19007595", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23403334", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24472162", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23272704", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24043965", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23408722", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24058912", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22161952", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22309452", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22710483", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25424139", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23845576", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24576837", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23280998", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23890156", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24124732", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23498672", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22903654", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23498674"
    ], 
    "ideal_answer": [
        "T1 mapping can quantitatively characterize myocardial tissue, in particular diffuse and interstitial fibrosis, edema in both overt and subclinical cardiophyopathies. However more research is required before a large-scale application for clinical decision-making can be recommended.", 
        "The clinical indication of cardiac T1 mapping magnetic resonance is the detection  of diffuse myocardial fibrosis in nonischemic cardiomyopathies"
    ], 
    "exact_answer": [
        "detection  of myocardial fibrosis in nonischemic cardiomyopathies", 
        "T1 mapping can quantitatively characterize myocardial tissue, i.e. fibrosis and edema."
    ], 
    "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D008279", 
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D006321"
    ], 
    "type": "factoid", 
    "id": "533ba218fd9a95ea0d000007", 
    "snippets": [
        {
            "offsetInBeginSection": 504, 
            "offsetInEndSection": 671, 
            "text": "More diverse patterns of late enhancement including patchy, mid-wall, subepicardial, or diffuse enhancement are of interest in diagnosing nonischemic cardiomyopathies.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22903654", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1102, 
            "offsetInEndSection": 1339, 
            "text": "Methods for quantification of T1 and extracellular volume fraction are emerging to tackle the issue of discriminating globally diffuse fibrosis from normal healthy tissue which is challenging using conventional late enhancement methods. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22903654", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 474, 
            "offsetInEndSection": 593, 
            "text": "Recent T1 mapping techniques aim to overcome the limitations of late gadolinium enhancement to assess diffuse fibrosis.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24058912", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1282, 
            "offsetInEndSection": 1432, 
            "text": "T1 mapping techniques performed both with and without contrast are enabling quantification of diffuse myocardial fibrosis and myocardial infiltration.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23845576", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1857, 
            "offsetInEndSection": 2094, 
            "text": "Noncontrast T1 mapping has high diagnostic accuracy for detecting cardiac AL amyloidosis, correlates well with markers of systolic and diastolic dysfunction, and is potentially more sensitive for detecting early disease than LGE imaging.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23498672", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 277, 
            "offsetInEndSection": 544, 
            "text": "T1 mapping has been proposed as potentially valuable in the quantitative assessment of diffuse myocardial fibrosis, but no studies to date have systematically evaluated its role in the differentiation of healthy myocardium from diffuse disease in a clinical setting. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23498674", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 2141, 
            "offsetInEndSection": 2318, 
            "text": "This study demonstrates that native and post-contrast T1 values provide indexes with high diagnostic accuracy for the discrimination of normal and diffusely diseased myocardium.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23498674", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1454, 
            "offsetInEndSection": 1646, 
            "text": "T1 values lengthened with greater LVMI and correlated with the degree of biopsy-quantified fibrosis. This may provide a useful clinical assessment of diffuse myocardial fibrosis in the future.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23349348", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 12, 
            "offsetInEndSection": 115, 
            "text": "Cardiac magnetic resonance (CMR) T1 mapping has been used to characterize myocardial diffuse fibrosis. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23272704", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1846, 
            "offsetInEndSection": 1986, 
            "text": "In HCM and DCM, noncontrast T1 mapping detects underlying disease processes beyond those assessed by LGE in relatively low-risk individuals.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23071146", 
            "endSection": "abstract"
        }
    ]
}